Blood and marrow transplantation (BMT) within four weeks of Sars-Cov-2 infection is associated with increased risk of mortality: A national COVID cohort collaborative study

Authors

Meera Mohan, Clinical Cancer Center, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI
Nathaniel Verhagen, Medical college of Wisconsin, Milwaukee, WI
Aditya Shreenivas, Medical college of Wisconsin, Milwaukee, WI
Sabarinath Radhakrishnan, Medical college of Wisconsin, Milwaukee, WI
Binod Dhakal, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
Saurabh Chhabra, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
Michael A. Thompson, Advocate Aurora HealthFollow
Marcelo Pasquini, CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Froedtert & The Medical College Cancer Ctr., Milwaukee, WI
Anita D'Souza, Center for International Blood and Marrow Transplant Research, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
Mehdi Hamadani, The BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, WI
Aniko Szabo, Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI
Anai Kothari, Medical college of Wisconsin, Milwaukee, WI

Recommended Citation

Mohan M, Verhagen N, Shreenivas A, Radhakrishnan S, Dhakal B, Chhabra S, Thompson MA, Pasquini MC, D'Souza A, Hamadani M, Szabo A, Kothari A. Blood and Marrow Transplantation (BMT) within Four Weeks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study. Blood. 2022;140(Suppl 4):940-941. doi:10.1182/blood-2022-165413

Affiliations

Aurora Cancer Care

Type

Abstract